Russia allocates 1.7 billion rubles for free medications and medical aid
Russia allocates 1.7 billion rubles for free medications and medical aid
Russia allocates 1.7 billion rubles for free medications and medical aid
The Russian government has announced a major funding boost for free medications, medical supplies, and therapeutic nutrition. Over 1.7 billion rubles will be distributed to support eligible citizens across the country. Prime Minister Mikhail Mishustin signed the directive to release the additional funds. Sverdlovsk Oblast will receive more than 50 million rubles under the new allocation. This makes it the third-highest funded region in Russia for this purpose. The region already leads in pharmaceutical provisions, with 10.5 billion rubles set aside in its 2026 budget.
The support targets specific groups, including disabled individuals, Chernobyl survivors, combat veterans, and World War II participants. Each patient’s needs are assessed by their treating physician to determine the required medications and supplies.
Governor Denis Pasler has also supported measures to maintain housing allowances for medical workers. This comes as hospitals in the region undergo reorganisation. The additional funds will ensure continued access to essential medical support for vulnerable groups. Sverdlovsk Oblast’s significant allocation reflects its commitment to healthcare provisions. The directive reinforces existing regional efforts to assist eligible citizens.
German nursing care reform faces backlash over financial risks ahead of cabinet review
A €1.8 billion annual burden on pensions. Half of care home residents at risk of welfare. Why Germany's reform is under fire—and what happens next.
Region transforms healthcare with new hospitals and modernized rural clinics
From high-tech hospitals to rural clinic revamps, this region is rewriting its healthcare story. Thousands of patients will soon benefit from expanded access and cutting-edge facilities.
FDA panel with industry ties to review peptide injection safety in July
A controversial FDA panel, stacked with doctors profiting from peptides, will decide their fate. Will science or business interests shape the outcome?
Nursing homes in crisis as low wages spark staffing shortages and delays
Thousands wait for care as underpaid staff push nursing homes to the brink. Will strikes force a pay rise—or collapse the system further?